Long term follow-up of surgical treatment of hypertrophic obstructive cardiomyopathy (HOCM):: the role of concomitant cardiac procedures

被引:14
|
作者
Minami, K [1 ]
Boethig, D [1 ]
Woltersdorf, H [1 ]
Seifert, D [1 ]
Körfer, R [1 ]
机构
[1] Univ Bochum, Dept Thorac & Cardiovasc Surg, Heart Ctr NRW, D-32545 Bad Oeynhausen, Germany
关键词
hypertrophic obstructive cardiomyopathy; mitral insufficiency; concomitant procedures;
D O I
10.1016/S1010-7940(02)00254-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In patients who underwent transaortic myectomy for hypertrophic obstructive cardiomyopathy (HOCM), we evaluated the role of concomitant procedures for short and lone term outcome. Methods: From 1985 to 2000, in 125 patients a myectomy according to Morrow was performed. A total of 75 patients (group 1) had isolated HOCM: 37 females, 38 males, mean age 52.1 years (14-79). The 50 patients of group II - 22 females, 28 males, mean age 62.4 years (36-77)-had concomitant procedures: coronary artery bypass grafting (36), mitral valve repair (15), DeVega-plasty (1), ventricular septal infarction-closure (1). Follow-up data of a total of 680.9 years (mean 5.4) were analyzed. Results: Postoperatively, left ventricular outflow tract gradients at rest and after ventricular premature beats were significantly reduced (P < 0.001). Mean performance of survivors (112/125 = 89.6%) improved significantly (P < 0.001). Perioperative complication rates: 10.7/12.0% (groups I/II), early lethality: 1.3/2.0%. Survival rates after 5/10 years were 93 +/- 3/87 +/- 6 and 80 +/- 7/80 +/- 7% for groups I and II, respectively. Conclusion: Long term results after surgical treatment of HOCM are convincing also if concomitant procedures are performed. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:206 / 210
页数:5
相关论文
共 50 条
  • [41] Patients with cardiac events during long-term follow-up after septal ablation for hypertrophic obstructive cardiomyopathy are characterized by the "classical" risk markers
    Faber, L.
    Welge, D.
    Fassbender, D.
    Schmidt, H. K.
    Gleichmann, U.
    Seggewiss, H.
    Horstkotte, D.
    EUROPEAN HEART JOURNAL, 2006, 27 : 957 - 958
  • [42] FOLLOW-UP AFTER NONSURGICAL SEPTAL REDUCTION IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    KNIGHT, CJ
    GUNNING, M
    HENEIN, M
    VECHT, R
    SUTTON, R
    GIBSON, DG
    SIGWART, U
    CIRCULATION, 1995, 92 (08) : 3757 - 3757
  • [43] THE LIVERPOOL EXPERIENCE OF ALCOHOL SEPTAL ABLATION (ASA) IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY (HOCM): 12 YEAR FOLLOW UP
    Cooper, R. M.
    Shahzad, A.
    Stables, R. H.
    HEART, 2013, 99 : A90 - A90
  • [44] Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
    Maron, Martin S.
    Rastegar, Hassan
    Dolan, Noreen
    Carpino, Philip
    Koethe, Benjamin
    Maron, Barry J.
    Rowin, Ethan J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 163 : 91 - 97
  • [45] Long term follow up of hypertrophic cardiomyopathy patients treated with non surgical septal reduction
    Harrington, D
    Knight, C
    Sigwart, U
    CIRCULATION, 1999, 100 (18) : 76 - 76
  • [46] ROLE OF DRUG THERAPY IN SURGICAL TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Abrolov, H. K.
    Mirsaidov, M. M.
    Alimov, A. B.
    Murodov, U. A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 163 : S65 - S65
  • [47] Surgical treatment of obstructive hypertrophic cardiomyopathy: the role of mitral valve
    Raffa, Giuseppe M.
    Romano, Giuseppe
    Falletta, Calogero
    Morsolini, Marco
    Turrisi, Marco
    Gentile, Giovanni
    Nugara, Cinzia
    Scarlata, Maria
    Clemenza, Francesco
    Pilato, Michele
    GIORNALE ITALIANO DI CARDIOLOGIA, 2019, 20 (02) : 109 - 116
  • [48] Dual-chamber pacing and alcohol septal ablation in hypertrophic obstructive cardiomyopathy - results of long-term follow-up
    Krejci, J.
    Gregor, P.
    Zemanek, D.
    Zidova, K.
    Curila, K.
    Stepanova, R.
    Novak, M.
    Groch, L.
    Veselka, J.
    EUROPEAN HEART JOURNAL, 2013, 34 : 537 - 537
  • [49] Long-term Clinical Follow-Up of Patients Undergoing Percutaneous Alcohol Septal Reduction for Symptomatic Obstructive Hypertrophic Cardiomyopathy
    de Cano, Silvia Fortunato
    Cano, Manuel Nicolas
    Costa, Jose de Ribamar, Jr.
    Pinheiro, Jairo Alves, Jr.
    de Mattos Barretto, Rodrigo Bellio
    de Souza Le Bihan, David Costa
    Abizaid, Alexandre
    Sousa, Amanda
    Eduardo Sousa, J.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 88 (06) : 953 - 960
  • [50] Catheter-Based Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Long-Term Follow-Up 1996-2016
    Faber, Lothar
    Gleichmann, Ulrich
    Horstkotte, Dieter
    Seggewiss, Hubert
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (04) : 276 - 281